TaqMan RT-PCR and VERSANT® HIV-1 RNA 3.0 (bDNA) assay
- 23 March 2005
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 34 (4) , 253-256
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Quantitation of Human Immunodeficiency Virus Type 1 in Breast MilkJournal of Clinical Microbiology, 2003
- Breast‐Milk Infectivity in Human Immunodeficiency Virus Type 1–Infected MothersThe Journal of Infectious Diseases, 2003
- Longitudinal Analysis of Human Immunodeficiency Virus Type 1 RNA in Breast Milk and of Its Relationship to Infant Infection and Maternal DiseaseThe Journal of Infectious Diseases, 2003
- Multicenter evaluation of the Bayer VERSANT™ HIV-1 RNA 3.0 assay: analytical and clinical performanceJournal of Clinical Virology, 2002
- Comparative Analysis of HIV-1 Viral Load Assays on Subtype Quantification: Bayer Versant HIV-1 RNA 3.0 Versus Roche Amplicor HIV-1 Monitor Version 1.5JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Real-Time TaqMan PCR as a Specific and More Sensitive Alternative to the Branched-Chain DNA Assay for Quantitation of Simian Immunodeficiency Virus RNAAIDS Research and Human Retroviruses, 2001
- Prevention of Mother-to-Child HIV Transmission in Resource-Poor CountriesJAMA, 2000
- Human Immunodeficiency Virus Load in Breast Milk, Mastitis, and Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1999
- Risk of human immunodeficiency virus type 1 transmission through breastfeedingThe Lancet, 1992
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986